Cargando…

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer

Novel treatments for castration-resistant prostate cancer (CRPC) such as abiraterone acetate (AA) or enzalutamide effectively target the androgen pathway to arrest aberrant signalling and cell proliferation. Testosterone is able to inhibit tumour cell growth in CRPC. Estrogen receptor-beta (ERβ) bin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bremmer, Felix, Jarry, Hubertus, Unterkircher, Valerie, Kaulfuss, Silke, Burfeind, Peter, Radzun, Heinz-Joachim, Ströbel, Philipp, Thelen, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908297/ https://www.ncbi.nlm.nih.gov/pubmed/29682196 http://dx.doi.org/10.18632/oncotarget.24763

Ejemplares similares

Prospects of estrogen receptor β activation in the treatment of castration-resistant prostate cancer
por: Gehrig, Julia, et al.
Publicado: (2017)

Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours
por: Bremmer, Felix, et al.
Publicado: (2015)

N-cadherin expression in malignant germ cell tumours of the testis
por: Bremmer, Felix, et al.
Publicado: (2012)

Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)
por: Bremmer, Felix, et al.
Publicado: (2014)

CK19 is a sensitive marker for yolk sac tumours of the testis
por: Bremmer, Felix, et al.
Publicado: (2015)

Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon
por: Dierks, Sascha, et al.
Publicado: (2015)

Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis
por: Bürger, Tobias, et al.
Publicado: (2015)

Phytoestrogens regulate the proliferation and expression of stem cell factors in cell lines of malignant testicular germ cell tumors
por: HASIBEDER, ASTRID, et al.
Publicado: (2013)

Sertoliform cystadenoma: a rare benign tumour of the rete testis
por: Bremmer, Felix, et al.
Publicado: (2013)

N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinoma
por: Behnes, Carl Ludwig, et al.
Publicado: (2012)

Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
por: Lam, Hung-Ming, et al.
Publicado: (2018)

“Prostate telocytes change their phenotype in response to castration or testosterone replacement”
por: Felisbino, Sérgio Luis, et al.
Publicado: (2019)

Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors
por: Klümper, Niklas, et al.
Publicado: (2015)

13-year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia
por: Behnes, Carl Ludwig, et al.
Publicado: (2013)

Discordance between testosterone measurement methods in castrated prostate cancer patients
por: Rouleau, Mélanie, et al.
Publicado: (2019)

Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines
por: Bremmer, Felix, et al.
Publicado: (2019)

Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
por: Ozyigit, Gokhan, et al.
Publicado: (2019)

Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α
por: KAULFUSS, SILKE, et al.
Publicado: (2015)

Pleural malakoplakia caused by Rhodoccocus equi infection in a patient after stem cell transplantation
por: Behnes, Carl Ludwig, et al.
Publicado: (2012)

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
por: Caramella, Irene, et al.
Publicado: (2022)

In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol
por: Hermann, Robert Michael, et al.
Publicado: (2008)

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer
por: Simms, M S, et al.
Publicado: (2000)

Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
por: Miura, Noriyoshi, et al.
Publicado: (2020)

Evaluation of chemical castration with calcium chloride versus surgical castration in donkeys: testosterone as an endpoint marker
por: Ibrahim, Ahmed, et al.
Publicado: (2016)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats
por: Rostami, Bahar, et al.
Publicado: (2014)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
por: Morote, Juan, et al.
Publicado: (2017)

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer
por: Sakamoto, Shinichi, et al.
Publicado: (2019)

Erratum to: Evaluation of chemical castration with calcium chloride versus surgical castration in donkeys: testosterone as an endpoint marker
por: Ibrahim, Ahmed, et al.
Publicado: (2016)

Cleistanthins A and B Ameliorate Testosterone-Induced Benign Prostatic Hyperplasia in Castrated Rats by Regulating Apoptosis and Cell Differentiation
por: S C, Santosh Kumar, et al.
Publicado: (2022)

Effect of testosterone replacement or duration of castration on baroreflex bradycardia in conscious rats
por: Ward, Gregg R, et al.
Publicado: (2005)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer
por: de Liaño, A G, et al.
Publicado: (2014)

Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer
por: Moses, Marcus, et al.
Publicado: (2020)

Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
por: Meller, B., et al.
Publicado: (2015)

Testosterone modulation of ethanol effects on the µ-opioid receptor kinetics in castrated rats
por: Khalil, Rafaat, et al.
Publicado: (2019)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Direct Effects of Testosterone, Dihydrotestosterone and Estrogen on 3,2′‐Dimethyl‐4‐aminobiphenyl‐induced Prostate Carcinogenesis in Castrated F344 Rats
por: Mori, Toshio, et al.
Publicado: (1996)

Cell-Free DNA Plasma Levels Differ in Age-Specific Pattern in Healthy Rats and Castrates with Testosterone-Induced Benign Prostatic Hyperplasia
por: Vasilyeva, I. N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_54e3kp6vdfmbc6i724afkkd337